Common drug linked to hampering lung cancer treatment – Devdiscourse

According to a new research by the Flinders University, a common medicine that treats reflux, heartburn as well as ulcers can hinder the effectiveness of lung cancer immunotherapy medicines. The findings of this research were published in the ‘British Journal…

Click here to view the original article.